SS
CLGN icon

SBI Securities’s CollPlant Biotechnologies CLGN Stock Holding History

SBI Securities’s Portfolio CLGN Stock Details CLGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$70 Hold
200
– – ﹤0.01% 3594
2026
Q1 		$107 Hold
200
– – ﹤0.01% 3387
2025
Q4 		$280 Sell
200
-1
-0.5% -$2 ﹤0.01% 3098
2025
Q3 		$541 Buy
201
+1
+0.5% +$2 ﹤0.01% 2935
2025
Q2 		$272 Hold
200
– – ﹤0.01% 3215
2025
Q1 		$516 Hold
200
– – ﹤0.01% 2863
2024
Q4 		$720 Buy
+200
New +$813 ﹤0.01% 2752

Other funds holding CLGN

PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $838M AUM 14.24% 1-Year Est. Return
WPC
Waters Parkerson & Co New Orleans, Louisiana $2.03B AUM 17.65% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.99% 1-Year Est. Return
SFG
Strive Financial Group Carmel, Indiana $231M AUM
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return

SBI Securities's CLGN Position: Q2 2026 in Review

SBI Securities held its CollPlant Biotechnologies (CLGN) position steady in Q2 2026 at 200 shares worth $70. The position accounts for ﹤0.01% of the portfolio, ranked #3594.

SBI Securities first reported a position in CLGN in Q4 2024 and has held it in 7 quarters since. The position peaked at $720 in Q4 2024. 7 funds tracked by Wall St. Rank hold CLGN as of Q2 2026.

  • SBI Securities held 200 shares of CollPlant Biotechnologies worth $70 as of Q2 2026.
  • SBI Securities left its CollPlant Biotechnologies share count unchanged in Q2 2026.
  • CollPlant Biotechnologies made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3594 holding.
  • SBI Securities first reported a position in CollPlant Biotechnologies in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's CollPlant Biotechnologies position peaked at $720 in Q4 2024.
  • 7 funds tracked by Wall St. Rank held CollPlant Biotechnologies as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.